Phenotypic and genotypic characterization of antimicrobial resistance profiles in Streptococcus dysgalactiae isolated from bovine clinical mastitis in 5 provinces of China by Zhang, Shiyao et al.
3344
J. Dairy Sci.  101 :3344–3355
https://doi.org/ 10.3168/jds.2017-14031 
© American Dairy Science Association®,  2018 .
ABSTRACT
Bovine mastitis is among the most prevalent and 
costly diseases of dairy animals and is caused by a 
variety of bacterial pathogens including Streptococcus 
dysgalactiae. However, comprehensive studies reporting 
the prevalence and antimicrobial resistance profiles of 
S. dysgalactiae isolated from bovine mastitis are scarce. 
Therefore, this study was to investigate the occurrence 
of S. dysgalactiae associated with bovine clinical mas-
titis, to assess their antimicrobial resistance profiles, 
and to analyze the phenotypic and genotypic profil-
ing of resistant isolates. In total, 1,180 milk samples 
were collected from dairy cows with clinical mastitis 
belonging to 74 commercial dairy herds located in 14 
provinces of China from January 2014 to May 2016. 
Overall S. dysgalactiae isolates were recovered from 88 
(7.5%) of the mastitic milk samples. The antimicro-
bial susceptibility of these isolates was tested against 
8 antimicrobial agents by using minimum inhibitory 
concentrations. Results showed that 82 (93.2%) isolates 
expressed resistance to more than one antimicrobial 
agent. Antimicrobial resistance was highest against 
kanamycin (89.8%), sulfonamide (83.0%), and strepto-
mycin (58.0%), which can be attributed to the intrinsic 
resistance for most of Streptococcus spp. against those 
antimicrobial substances. Strikingly, 30 (34.1%) and 
12 (13.6%) isolates were found resistant to cephalexin 
and ceftriaxone, respectively. BlaTEM, ermB, and tetM
were the most prevalent resistance genes. All isolates 
carried at least one of all tested resistance genes. Also, 
1.1, 12.5, 18.2, 36.4, and 31.8% of isolates were positive 
for at least one tested resistance gene in 1, 2, 3, 4, or 
5 classes of antimicrobials. Survival analysis showed a 
significant association between ermB and survival of 
the S. dysgalactiae isolates at increasing erythromycin 
concentrations. No other statistically significant as-
sociations were observed between the phenotypic and 
genotypic resistance profiles. This study concludes a 
considerable prevalence of S. dysgalactiae associated 
with bovine mastitis in dairy herds of China and these 
isolates exhibited high resistance rates to tested anti-
microbials, coupled with high occurrence of resistance 
genes. Both the prevalence of S. dysgalactiae and their 
antimicrobial resistance profiles strongly varied among 
dairy herds, demonstrating the need for antimicrobial 
susceptibility surveillance at the herd level to ensure 
optimal therapeutic results.
Key words: Streptococcus dysgalactiae, antimicrobial 
resistance, bovine clinical mastitis
INTRODUCTION
Bovine mastitis, inflammation of the mammary gland, 
is still the most prevalent disease in dairy cattle. The 
inflammatory reaction primarily occurs in response to 
bacterial IMI and impairs milk quality (Petrovski et al., 
2006; Halasa et al., 2007). This disease also accounts 
for the highest proportion of antimicrobial usage on 
a dairy farm (Saini et al., 2012; Kuipers et al., 2016; 
Stevens et al., 2016). It is estimated that 60 to 70% of 
all antimicrobials used on dairy farms is applied for the 
prevention and control of mastitis, of which roughly half 
is related to the treatment of clinical mastitis (Kuipers 
et al., 2016; Stevens et al., 2016). Mastitis is character-
ized by clinical signs of inflammation and alterations in 
the appearance of milk (i.e., clinical mastitis) or it may 
be without any visual abnormalities (i.e., subclinical 
mastitis). Clinical and subclinical mastitis also affect 
animal welfare (Peters et al., 2015).
Apart from one recent research work in which the 
prevalence of the most common mastitis pathogens was 
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studied in bulk milk samples collected from 894 Chi-
nese dairy farms (Bi et al., 2016) and one recent report 
about the incidence of clinical mastitis and distribution 
of pathogens on 161 large Chinese dairy farms (Gao 
et al., 2017), no other information is available on the 
prevalence and distribution of mastitis pathogens in 
Chinese dairy farms. Of particular interest in the first 
study was the high prevalence of Streptococcus dysga-
lactiae-positive bulk milk samples; S. dysgalactiae was 
detected in 72.3% of the bulk milk samples (Bi et al., 
2016). It was noteworthy that the prevalence of S. dys-
galactiae was significantly higher than the prevalence 
of other major mastitis pathogens such as Staphylococ-
cus aureus, Streptococcus agalactiae, and Streptococcus 
uberis (Gao et al., 2017), as well as in most other coun-
tries including Norway, Belgium, France, and Thailand 
(Piepers et al., 2007; Whist et al., 2007; Botrel et al., 
2010; Leelahapongsathon et al., 2014). Still, bacteria in 
bulk milk do not solely originate from infected quarters. 
Environmental contamination or insufficient hygiene 
and poor preservation conditions can also cause posi-
tive bulk milk samples (Elmoslemany et al., 2009a,b). 
To get better insights in the exact relevance of S. dys-
galactiae for the udder health in dairy cows in China, 
studies on the prevalence of S. dysgalactiae in clinical 
mastitis are required.
Despite the increasing pressure to reduce antimi-
crobial use in food-producing animals, antimicrobials 
still have important benefits for animal health and 
are still an essential tool in mastitis control programs 
(Middleton et al., 2014). Failure or success of treatment 
of clinical mastitis depends on several factors including 
those related to the cow such as age or parity, stage 
of lactation (DIM), SCC, and clinical mastitis history, 
and those related to the pathogen such as virulence and 
antimicrobial susceptibility (Sol et al., 2000; Taponen 
et al., 2003; Barkema et al., 2006). Antimicrobial resis-
tance surveillance studies are imperative to choose the 
most appropriate antimicrobial therapies and to reduce 
the risk for further development and spread of antimi-
crobial resistance through lateral transfer of resistance 
genes or direct transfer of resistant pathogens. Some 
information is available on the prevalence of phenotypic 
antimicrobial resistance in S. dysgalactiae (Guérin-
Faublée et al., 2002; Bengtsson et al., 2009; McDougall 
et al., 2014; Petrovski et al., 2015), though no studies 
have comprehensively investigated the genotypic anti-
microbial resistance in S. dysgalactiae.
The main objective of the current study was to es-
timate the prevalence of clinical mastitis caused by S. 
dysgalactiae in Chinese dairy herds and to determine the 
prevalence of both phenotypic and genotypic antimicro-
bial resistance profiles of the collected S. dysgalactiae 
isolates. Additionally, results obtained by phenotypic 
and genotypic profiling of antimicrobial resistance were 
compared.
MATERIALS AND METHODS
Data and Sample Collection
Streptococcus dysgalactiae isolates included in this 
study were collected from milk samples of dairy cows 
with clinical mastitis (n = 1,180). In total, 74 dairy 
farms located in 14 different provinces were involved 
in the study (Beijing = 23 milk samples; Tianjin = 85 
samples; Hebei = 196 samples; Shandong = 87 samples; 
Shaanxi = 26 samples; Shanxi = 48 samples; Inner 
Mongolia = 321 samples; Guangdong = 98 samples; 
Shanghai = 47 samples; Henan = 17 samples; Anhui 
= 78 samples; Heilongjiang = 56 samples; Jilin = 25 
samples; Liaoning = 73 samples). On each farm, all 
the dairy farms veterinarians were requested to report 
the signs of clinical mastitis cases along with asepti-
cally collected milk samples between January 2014 and 
May 2016. In case that only one quarter was affected, 
sample was taken from the quarter showing signs of 
clinical mastitis. If 2 or more quarters showed clinical 
signs at the same time, a composite milk sample from 
all quarters showing clinical signs [any abnormal aspect 
of the milk (flakes, clots, and a watery or other unusual 
appearance) with or without other visible abnormalities 
of the udder (e.g., redness, swelling, firmness)] was col-
lected. Sample materials were provided and sampling 
procedures were explained in light of National Mastitis 
Council (NMC, 1999) instructions as well as the impor-
tance of an aseptic sampling procedure. Samples taken 
from the same cow within 3 mo from a previous case 
were excluded from the analysis. All the milk samples 
for bacteriological culturing were transported in ice 
boxes to our Bovine Mastitis Research Laboratory at 
the College of Veterinary Medicine, China Agricultural 
University, Beijing, China.
Microbiology
A volume of 30 µL from each of the composite milk 
samples was plated on a tryptic soy agar (TSA; Oxoid, 
Basingstoke, UK) containing 5% defibrinated sheep 
blood (Land Bridge Technology, Beijing, China) and 
incubated aerobically at 37°C for 24 h. Subsequently, 
the identification of Streptococcus dysgalactiae was 
carried out by Gram staining, colony morphology, and 
biochemical tests. Streptococci (catalase-negative) were 
differentiated from staphylococci (catalase-positive) 
using catalase test. Isolates of the Streptococcus-En-
terococcus group were differentiated as esculin-positive 
(Streptococcus uberis and other esculin-positive cocci) 
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or esculin-negative cocci (S. dysgalactiae and S. agalac-
tiae). Christie, Atkins, and Munch-Petersen (CAMP) 
test was used to differentiate S. dysgalactiae (CAMP-
negative) from Streptococcus agalactiae (CAMP-pos-
itive). Samples yielding 2 different bacterial colonies 
were categorized as mixed culture. However, those 
samples which yielded 3 or more different bacterial 
colonies were considered contaminated.
In case that a sample was positive for S. dysgalactiae 
in pure or mixed culture, only one S. dysgalactiae colony 
was picked up per plate (i.e., per sample) for further 
analysis. All recovered isolates suspected of being S. 
dysgalactiae (n = 88) were subjected to 16S rRNA gene 
sequencing for the S. dysgalactiae species identification 
using universal primers as described previously (Frank 
et al., 2008). The purified PCR products (750 bp) were 
sequenced by an automated ABI 3730 sequencer (Bei-
jing Sunbiotech Inc., Beijing, China). The sequences 
were compared using Basic Local Alignment Search 
Tool tools at the National Center for Biotechnology In-
formation, and species were identified at 98% or above 
homology. All the isolates (n = 88) were confirmed as 
S. dysgalactiae, which were then stored in Brain Heart 
infusion broth (Aobox Biotechnology, Beijing, China) 
containing 25% glycerol at −80°C until further process-
ing.
Phenotypic Resistance Profiling
The stored isolates were thawed at 37°C. First, the 
isolates were grown on TSA blood agar plates (Oxoid). 
Then, fresh colonies were grown in Mueller-Hinton 
broth (Oxoid) containing 5% fetal bovine serum (Tian-
hang Biotechnology, Hangzhou, China) for 18 h at 
37°C. After bacterial growth, the bacterial suspension 
was plated on TSA blood agar plates in a serial dilution 
from 10−1 to 10−12 and the colonies were counted after 
20 h. The inoculum was adjusted to 5 × 105 cfu/mL.
Antimicrobial susceptibility of all the clinical S. dys-
galactiae isolates was tested against a panel of antimi-
crobials that are routinely used on Chinese dairy farms, 
by using standard microdilution broth method. The 
antimicrobial agents included cephalexin (≥4 µg/mL), 
ceftriaxone (≥4 µg/mL), erythromycin (≥1 µg/mL), 
kanamycin (≥16 µg/mL), norfloxacin (≥8 µg/mL), 
streptomycin (≥32 µg/mL), sulfonamide (≥32 µg/
mL), and tetracycline (≥8 µg/mL) using the guidelines 
and breakpoints of Clinical and Laboratory Standards 
Institute (Clinical and Laboratory Standards Institute, 
2015) where available. For this purpose, cationic-ad-
justed Mueller-Hinton broth (Oxoid) was supplemented 
with 5% lysed horse blood. Because no specific resis-
tance breakpoints for Streptococcus spp. were available 
for some tested antimicrobials, the resistance break-
points for either an antimicrobial of the same antimi-
crobial drug class (for cephalexin and norfloxacin) or 
another pathogen group [i.e., Enterobacteriaceae (for 
sulfonamide and kanamycin)] were referred to as rec-
ommended by the Clinical and Laboratory Standards 
Institute (2015). Minimum inhibitory concentrations 
were determined initially using a reference strain of 
Streptococcus pneumoniae ATCC 49619.
Antimicrobial Resistance Genotyping
Genotypic resistance profiles of clinical S. dysgalac-
tiae isolates were determined by PCR, assays target-
ing the genes encoding resistance to aminoglycosides, 
β-lactams, macrolide, quinolones, streptomycin, sulfon-
amides, and tetracyclines. Primers and PCR conditions 
were as previously described (Table 1).
All primers were commercially synthesized (Sunbio-
tech Inc.). To extract DNA, bacterial cells were sus-
pended in double-distilled water (TransGen Biotech, 
Beijing, China) and boiled for 20 min. Subsequently, the 
cells were pelleted by centrifugation (504 × g, at room 
temperature) for 1 min. Amplifications were carried out 
with 5 µL of the supernatants as DNA template (Ma-
tayoshi et al., 2015). The PCR was performed in a final 
volume of 25 µL using 2 × EasyTaq PCR SuperMix 
(+ dye; TransGen Biotech, Beijing, China). The PCR 
was performed with the following parameters: an initial 
denaturation cycle at 94°C for 5 min, followed by 35 
cycles of denaturation at 94°C for30 s, primer annealing 
at 58°C (52–66°C, determined by the primer) for 30 s, 
elongation at 72°C for 50 s, and a final cycle at 72°C 
for 10 min.
All PCR products were submitted to Sunbiotech Inc. 
for sequencing. The resulting DNA sequence data were 
compared with data in the GenBank database using the 
Basic Local Alignment Search Tool algorithm available 
at the National Center for Biotechnology Information 
website (www .ncbi .nlm .nih .gov).
Statistical Analysis
The frequency distributions of the MIC values for 
each antimicrobial were tabulated and presented graph-
ically. The antimicrobial concentration at which 50 and 
90% of the isolates were inhibited were represented by 
MIC50 and MIC90 values, respectively.
Survival analysis was used to plot survival of S. dys-
galactiae isolates with and without specified resistance 
genes against MIC values from relevant phenotypic as-
says. In these analysis, the time-to-event was given by 
the MIC. When an organism was still growing at the 
specified antimicrobial concentration, the observation 
was coded as censored. The Kaplan-Meier estimator 
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Table 1. Detailed information of the primers used to detect antimicrobial resistance genes in this study
Antimicrobial  
drug class  
Resistance  
gene  Primer sequence (5′→3′)
PCR product  
size (bp)
 
Reference
Aminoglycosides aphA-1 ATGGGCTCGCGATAATGTC 600 Sáenz et al., 2004
CTCACCGAGGCAGTTCCAT
 aphA-2 GAACAAGATGGATTGCACGC 680 Sáenz et al., 2004
GCTCTTCAGCAATATCACGG
 aphA-3 GGGGTACCTTTAAATACTGTAG 848 Poyart et al., 2003
TCTGGATCCTAAAACAATTCATCC
 aadA1/aadA2 GCAGCGCAATGACATTCTTG 282 Sáenz et al., 2004
ATCCTTCGGCGCGATTTTG
 aad-6 AGAAGATGTAATAATATAG 978 Poyart et al., 2003
CTGTAATCACTGTTCCCGCCT
β-Lactams blaIMP CTACCGCAGCAGAGTCTTTG 587 Sundsfjord et al., 2004
AACCAGTTTTGCCTTACCAT
 blaSHV ATGCGTTATATTCGCCTGTG 860 Sundsfjord et al., 2004
TTAGCGTTGCCAGTGCTCGA
 blaSPM-1 CCTACAATCTAACGGCGACC 649 Sundsfjord et al., 2004
TCGCCGTGTCCAGGTATAAC
 blaTEM ATGAGTATTCAACATTTTCGTG 860 Sundsfjord et al., 2004
TTACCAATGCTTAATCAGTGAG
 blaVIM ATTCCGGTCGGAGAGGTCCG 633 Sundsfjord et al., 2004
GAGCAAGTCTAGACCGCCCG
 mecA TGGCTATCGTGTCACAATCG 310 Sundsfjord et al., 2004
CTGGAACTTGTTGAGCAGAG
Macrolides ermA/TR TCAGGAAAAGGACATTTTACC 432 Sutcliffe et al., 1996
ATACTTTTTGTAGTCCTTCTT
ermB GAAAAGGTACTCAACCAAATA 639 Sutcliffe et al., 1996
AGTAACGGTACTTAAATTGTTTAC
ermC TCAAAACATAATATAGATAAA 642 Sutcliffe et al., 1996
GCTAATATTGTTTAAATCGTCAA
mdfA/mefE AGTATCATTAATCACTAGTGC 348 Sutcliffe et al., 1996
TTCTTCTGGTACTAAAAGTGG
Quinolones gyrA TTCTCCGATTTCCTCATG 458 de Toro et al., 2010
AGAAGGGTACGAATGTGG
 parC TGGGTTGAAGCCGGTTCA 361 de Toro et al., 2010
CAAGACCGTTGGTTCTTTC
Streptomycin rpsL GGCCGACAAACAGAACGT 501 Sreevatsan et al., 1996
GTTCACCAACTGGGTGAC
 rrs GAGAGTTTGATCCTGGCTCAG 1,042 Sreevatsan et al., 1996
TGCACACAGGCCACAAGGGA
Sulfonamides sul1 TGGTGACGGTGTTCGGCATTC 789 Sáenz et al., 2004
GCGAGGGTTTCCGAGAAGGTG
 sul2 CGGCATCGTCAACATAACC 722 Sáenz et al., 2004
GTGTGCGGATGAAGTCAG
 sul3 CATTCTAGAAAACAGTCGTAGTTCG 990 Sáenz et al., 2004
CATCTGCAGCTAACCTAGGGCTTTGGA
Tetracyclines tetA GTAATTCTGAGCACTGTCGC 937 Sáenz et al., 2004
CTGCCTGGACAACATTGCTT
 tetB CTCAGTATTCCAAGCCTTTG 416 Sáenz et al., 2004
CTAAGCACTTGTCTCCTGTT
 tetC TCTAACAATGCGCTCATCGT 570 Sáenz et al., 2004
GGTTGAAGGCTCTCAAGGGC
 tetD ATTACACTGCTGGACGCGAT 1,104 Sáenz et al., 2004
CTGATCAGCAGACAGATTGC
 tetE GTGATGATGGCACTGGTCAT 1,179 Sáenz et al., 2004
CTCTGCTGTACATCGCTCTT
 tetK GTAGGATCTGCTGCATTCCC 552 Poyart et al., 2003
CACTATTACCTATTGTCGC
 tetL GGATCGATAGTAGCCATGGG 516 Poyart et al., 2003
GTATCCCACCAATGTAGCCG
 tetM GTGGAGTACTACATTTACGAG 359 Poyart et al., 2003
GAAGCGGATCACTATCTGAG
 tetO GCGGAACATTGCATTTGAGGG 538 Poyart et al., 2003
CTCTATGGACAACCCGACAGAAG
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was used to estimate survival curves and the log-rank 
test was used to test for significant associations between 
gene presence and MIC value (Sampimon et al., 2011). 
The analysis was only performed for those resistance 
genes that were carried by at least 2 isolates. Hazard 
ratios and 95% confidence interval were calculated. 
Statistical significance was defined at P < 0.05.
RESULTS
Isolation and Identification  
of Streptococcus dysgalactiae
Overall, 88 clinical mastitis cases were culture posi-
tive for Streptococcus dysgalactiae. The prevalence of 
S. dysgalactiae was 7.5% from 1,180 milk samples col-
lected from dairy cows with clinical mastitis belonging 
to 74 commercial dairy herds located in 14 different 
provinces of China. Eighty-eight S. dysgalactiae isolates 
were isolated from 88 cows (i.e., one isolate from one 
cow) belonging to 17 dairy herds located in the 5 prov-
inces [i.e., Guangdong (n = 3), Hebei (n = 13), Inner 
Mongolia (n = 68), Shanghai (n = 1), and Shandong (n 
= 3); Figure 1 and Table 2]. Of the 88 S. dysgalactiae 
isolates, 19 isolates were recovered in pure culture, and 
69 isolates were recovered in combination with other 
mastitis pathogens, such as Escherichia coli and CNS. 
A high variation in the prevalence of S. dysgalactiae 
was observed among different dairy herds.
Phenotypic Resistance Profiles  
of Streptococcus dysgalactiae
Two out of 88 (2.3%) isolates were phenotypically sus-
ceptible to all the tested antimicrobials using the Clini-
cal and Laboratory Standards Institute breakpoints. 
Four (4.5%) isolates expressed resistance to a single 
compound, and 82 isolates (93.1%) showed resistance 
to more than one antimicrobial agent. Thirteen isolates 
were expressing resistance to 2 related compounds (i.e., 
to kanamycin and streptomycin), whereas 69 isolates 
were found to be resistant to compounds belonging to 
Figure 1. Distribution of Streptococcus dysgalactiae isolates recovered from milk samples of bovine clinical mastitis cases collected on Chinese 
dairy farms stratified by province. GD = Guangdong; HB = Hebei; IM = Inner Mongolia; SH = Shanghai; and SN = Shandong.
Table 2. Antimicrobial resistance rates of 88 Streptococcus dysgalactiae isolates recovered from milk samples of bovine clinical mastitis cases 
collected in 17 dairy herds stratified by province
Antimicrobial drug
No. (%) of resistant isolates stratified by province
Total % 
(n = 88)
Guangdong 
(n = 3)
Hebei 
(n = 13)
Inner Mongolia 
(n = 68)
Shanghai 
(n = 1)
Shandong 
(n = 3)
Cephalexin 0 (0) 0 (0) 30 (44.1) 0 (0) 0 (0) 34.1
Ceftriaxone 1 (33.3) 0 (0) 11 (16.2) 0 (0) 0 (0) 13.6
Erythromycin 0 (0) 4 (30.8) 37 (54.4) 0 (0) 1 (33.3) 47.7
Kanamycin 3 (100) 11 (84.6) 61 (89.7) 1 (100) 3 (100) 89.8
Norfloxacin 1 (33.3) 4 (30.8) 10 (14.7) 0 (0) 1 (33.3) 18.2
Streptomycin 1 (33.3) 7 (53.8) 42 (61.8) 1 (100) 1 (33.3) 58.0
Sulfonamide 3 (100) 4 (30.8) 57 (83.8) 1 (100) 3 (100) 83.0
Tetracycline 1 (33.3) 1 (7.7) 27 (39.7) 0 (0) 0 (0) 33.0
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different antimicrobial classes (Figure 2). Only 12 of 
30 isolates that showed resistance against cephalexin 
were also found to be resistant to ceftriaxone. The anti-
microbial agents to which antimicrobial resistance was 
demonstrated most frequently were kanamycin (89.8%), 
sulfonamide (83.0%), and streptomycin (58.0%). Ceftri-
axone (13.6%) and norfloxacin (18.2%) were the anti-
microbial agents with the lowest level of antimicrobial 
resistance. Importantly, 30 (34.1%) and 12 (13.6%) 
isolates were also found to be resistant against the first 
(cephalexin) and third (ceftriaxone) generation cepha-
losporins, respectively (Table 3).
Also, the lowest MIC50 and MIC90 values were ob-
served for ceftriaxone (0.06 and 4 µg/mL, respectively) 
and cephalexin (0.5 and 8 µg/mL, respectively), where-
as the highest MIC50 and MIC90 values were noted for 
kanamycin, streptomycin, and sulfonamide (64 and 128 
µg/mL, respectively; Table 3).
Herds 9, 10, 11, and 12 had a relatively higher preva-
lence of S. dysgalactiae as compared with other herds. 
Moreover, in those 4 herds various groups of resistant 
S. dysgalactiae isolates exhibiting different resistant 
patterns were observed (Table 4). For example, in herd 
9, 5 categories of resistant S. dysgalactiae isolates could 
be distinguished, and 9, 12, and 9 categories in herd 10, 
11, and 12, respectively. The latter categories showed 
resistance to 2, 3, 5, 6, and 7 different classes of antimi-
crobials, respectively.
Figure 2. Distribution of phenotypically resistant Streptococcus dysgalactiae isolates recovered from milk samples of bovine clinical mastitis 
cases collected on Chinese dairy herds. Different numbers of antimicrobial drugs (i.e., 0, 1, 2, 3, 4, 5, 6, or 7) showed resistance to various clini-
cal isolates from mastitic cows in 17 dairy herds. 0 = no isolate was resistant to any tested drug; 1 = isolates resistant to one drug; 2 = isolates 
resistant to 2 drugs, and so on.
Table 3. Minimum inhibitory concentrations of Streptococcus dysgalactiae isolates recovered from milk samples of bovine clinical mastitis cases 
(n = 88) showing MIC50 and MIC90
1
Antimicrobial  
agent
Range of  
antimicrobial (µg/mL)
Resistance  
breakpoint2 (µg/mL)
MIC range  
(µg/mL)
MIC50 
(µg/mL)
MIC90 
(µg/mL)
Resistance 
rate (%)
Cephalexin 0.03–256 ≥4 0.06–128 0.5 8 34.1
Ceftriaxone 0.03–256 ≥4 0.06–64 0.06 4 13.6
Erythromycin 0.03–256 ≥1 0.06–128 0.5 128 47.7
Kanamycin 0.03–256 ≥16 0.5–128 64 128 89.8
Norfloxacin 0.03–256 ≥8 0.25–64 2 17.6 18.2
Streptomycin 0.5–256 ≥32 1–128 64 128 58.0
Sulfonamide 0.5–256 ≥32 4–128 64 128 83.0
Tetracycline 0.03–256 ≥8 1–128 4 70.4 33.0
1MIC50 represents the antimicrobial concentration at which 50% of the isolates were inhibited. MIC90 represents the antimicrobial concentration 
at which 90% of the isolates were inhibited.
2Resistance breakpoints based on Clinical and Laboratory Standards Institute (2015).
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Genotypic Resistance Profiles  
of Streptococcus dysgalactiae
None of the S. dysgalactiae isolates was negative for 
all resistance genes tested by PCR amplification. In 
summary, 1.1, 12.5, 18.2, 36.4, and 31.8% of isolates 
were positive for at least one tested resistance gene in 
1, 2, 3, 4, or 5 antimicrobial drug classes (Figure 3).
Of all 31 tested resistance genes, blaTEM (n = 75) 
was detected the most prevalent gene by PCR, followed 
by tetM (n = 66), sul1 (n = 63), and ermB (n = 52; 
Table 5). A single isolate was positive for blaSPM-1, 
mdfA/mefE, ermC, tetD, and gyrA, whereas many other 
antimicrobial resistance genes were even not detected 
although the isolates showed phenotypic resistance 
against antimicrobials in the specific antimicrobial drug 
class (Table 5). Table 6 depicts the prevalence of dif-
ferent phenotypically resistant S. dysgalactiae isolates 
exhibiting resistance to 8 different antimicrobial agents 
and the occurrence of different resistance genes among 
these isolates. Overall, 5 resistance genes (aphA-1, 
aphA-2 aphA-2 aphA-3, aadA1/aadA2, and aad-6) en-
coding for aminoglycoside resistance, 3 resistance genes 
(blaTEM, blaIMP, blaSPM-1) encoding for β-lactams, 
4 genes (ermA/TR, ermB, mdfA/mefE, ermC) respon-
sible for resistance to macrolides, 1 gene (gyrA) respon-
sible for quinolone resistance, 1 gene (rrs) encoding for 
streptomycin resistance, 2 genes (sul1, sul2) encoding 
Table 4. Number of Streptococcus dysgalactiae isolates with different phenotypic resistance profiles isolated from the 4 herds with the highest 
prevalence of Streptococcus dysgalactiae
Antimicrobial 
drug
Herd 9
 
Herd 10
 
Herd 11
 
Herd 12
21 4 2 2 2 1 1 3 1 1 1 1 1 1 2 2 3 1 1 1 3 1 1 7 1 1 2 1 1 1 2 1 1 3 3
Cephalexin  −2 − − −  +3 + + + + + + − + + − − − − − − − + + + + + − − + − − − − + +
Ceftriaxone − − − − + − − − − − − − − + − − − − − − + − + − − + − − − − − − − + −
Erythromycin − − − + + − − − − + + + + + − − − − + + + + + + − + − − − + + + + + +
Kanamycin + + + + + − + + + + + + + − + + − + + + + + + + − + + + + + + + + +
Norfloxacin − + + + − + − − + − − − − − − − − − − − − + + − − − − − + − − −
Streptomycin + + + + − + + + + + + + + − − + + + − + − + + + + − + − − + − + − +
Sulfonamide − + + + + − + + − − + + + + − − − + − + − + − + + + + + + + + + + + +
Tetracyclin − − + + + − − − − + + + + − − − + − − − − − + + + − − − − − − + + +
1Number of resistant isolates.
2− = absence of phenotypic resistance against the specific antimicrobial.
3+ = presence of phenotypic resistance against the specific antimicrobial.
Figure 3. Distribution of the number of genotypically resistant Streptococcus dysgalactiae isolates stratified by the number of antimicrobial 
drug classes of which at least one resistance gene of the corresponding class was amplified (i.e., 1, 2, 3, 4, or 5). 1 = the detected resistance 
gene(s) belonged to one antimicrobial drug class; 2 = the detected resistance genes belonged to 2 different antimicrobial drug classes; 3 = the 
detected resistance genes belonged to 3 different antimicrobial drug classes; 4 = the detected resistance genes belonged to 4 different antimicro-
bial drug classes; 5 = the detected resistance genes belonged to 5 different antimicrobial drug classes.
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for sulfonamide resistance, and 5 genes (tetD, tetK, 
tetL, tetM, tetO) encoding for tetracycline resistance, 
in various frequencies detected as shown in Table 6.
Association Between Phenotypic and Genotypic 
Resistance Profiles
The survival analysis was performed only for those 
resistance genes that were carried by at least 2 S. 
dysgalactiae isolates (Table 7). For instance, a single 
isolate was found positive for blaSPM-1, mdfA/mefE, 
ermC, tetD, and gyrA; therefore, we did not per-
form the survival analysis for these resistance genes. 
For other genes, such as blaTEM, blaIMP, blaTEM, 
blaIMP, ermA/TR, ermB, sul1, sul2, tetM, tetK, and 
tetO, survival analysis was assessed. The results of sur-
vival analysis in all S. dysgalactiae isolates showed a 
significant association between the presence of ermB 
and survival at increasing erythromycin concentrations 
as shown in Figure 4 (log rank statistic, chi-squared 
5.05, 1 df, P = 0.02). However, survival at increas-
ing erythromycin concentrations did not differ between 
ermA/TR positive and negative isolates. Additionally, 
survival at increasing cephalexin concentrations tended 
to be associated with the presence of the blaIMP gene 
(log rank statistic, chi-squared 3.6, 1 df, P = 0.06). 
Nevertheless, no significant associations were observed 
between the survival of the S. dysgalactiae isolates at 
increasing concentrations of other tested antimicrobial 
drugs and the presence of the specific resistance genes 
(Table 7).
DISCUSSION
This is the first comprehensive study to investigate 
both the phenotypic and genotypic antimicrobial re-
sistance profiles of S. dysgalactiae bacteria originating 
from dairy cows that suffered from clinical mastitis in 
Chinese dairy farms. The generated data set was rather 
unique and allowed us to get better insights into the 
prevalence and the resistance of S. dysgalactiae as a 
cause of clinical mastitis in dairy cows in China because 
a large number of cows belonging to 74 different herds 
located in not less than 14 Chinese provinces were in-
cluded, and as all milk samples were processed by 1 
laboratory.
Table 5. Distribution of antimicrobial resistance genes detected in Streptococcus dysgalactiae isolates (n = 88) recovered from milk samples of 
bovine clinical mastitis cases collected on 17 dairy farms stratified by province
Antimicrobial  
resistance gene
No. of isolates carrying the specific antimicrobial resistance gene stratified by province
Total 
(n = 88)
Guangdong 
(n = 3)
Hebei 
(n = 13)
Inner Mongolia 
(n = 68)
Shanghai 
(n = 1)
Shandong 
(n = 3)
aphA-1 2 5 25 0 0 32
aphA-2 0 0 12 0 0 12
aphA-3 0 0 9 0 0 9
aadA1/aadA2 0 0 22 0 0 22
aad-6 0 0 14 0 0 14
blaTEM 3 9 60 1 2 75
blaIMP 1 0 15 0 0 16
blaSPM-1 0 0 1 0 0 1
blaVIM 0 0 0 0 0 0
blaSHV 0 0 0 0 0 0
mecA 0 0 0 0 0 0
ermA/TR 2 4 1 1 0 8
ermB 1 10 38 1 2 52
mdfA/mefE 0 1 0 0 0 1
ermC 0 0 1 0 0 1
gyrA 0 0 1 0 0 1
parC 0 0 0 0 0 0
rrs 1 0 3 0 0 4
rpsL 0 0 0 0 0 0
sul1 2 13 45 0 3 63
sul2 2 7 27 0 0 36
sul3 0 0 0 0 0 0
tetA 0 0 0 0 0 0
tetB 0 0 0 0 0 0
tetC 0 0 0 0 0 0
tetD 0 0 1 0 0 1
tetE 0 0 0 0 0 0
tetK 1 0 3 0 0 4
tetL 2 3 15 0 0 20
tetM 2 12 49 0 3 66
tetO 2 4 25 0 0 31
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In the current study, the prevalence of S. dysgalac-
tiae causing clinical mastitis was relatively lower than 
the other reported studies; however, a large variation 
among herds within the same province was observed. 
Approximately 7.5% of the tested milk samples was 
found to be culture positive for S. dysgalactiae. The 
isolation rate was much lower than the 72.3% isolation 
of S. dysgalactiae from bulk milk samples (Bi et al., 
2016). This considerable difference in the prevalence 
of S. dysgalactiae might at least partly be explained 
by the fact that bulk milk samples not only contain 
bacteria present in the milk of infected quarters, but 
might also be contaminated by bacteria coming from 
the milking equipment and environment (Elmoslemany 
et al., 2009a,b). Still, the prevalence of S. dysgalac-
tiae from clinical mastitis in our study was consistent 
with the prevalence of 10.5% from clinical mastitis in 
China (Gao et al., 2017), 12.1% from clinical mastitis 
in Norway (Whist et al., 2007), and 4.0% from clinical 
mastitis in Thailand (Leelahapongsathon et al., 2014).
Antimicrobial susceptibility was determined using 
serial dilutions and determination of the minimal in-
hibitory concentrations instead of common agar disc-
diffusion assays. It might be helpful to adjust the thera-
Table 6. Prevalence of phenotypically resistant Streptococcus dysgalactiae isolates stratified by antimicrobial drug that carried the tested 
antimicrobial resistance genes
Antimicrobial 
drug class  
Antimicrobial 
resistance  
gene
No. (%) of isolates that showed antimicrobial resistance against the specified antimicrobial drug1
CX 
(n = 30)
CRO 
(n = 12)
E 
(n = 42)
NOR 
(n = 16)
K 
(n = 79)
S 
(n = 52)
SM 
(n = 68)
TE 
(n = 29)
Aminoglycosides aphA-1 10 (33.3) 4 (33.3) 19 (45.2) 1 (6.3) 26 (32.9) 22 (42.3) 22 (32.4) 7 (24.1)
aphA-2 6 (20.0) 4 (33.3) 8 (19.0) 1 (6.3) 11 (13.9) 5 (9.6) 8 (11.8) 3 (10.3)
aphA-3 0 (0) 0 (0) 4 (9.5) 5 (31.3) 8 (10.1) 9 (17.3) 9 (13.2) 7 (24.1)
aadA1/aadA2 8 (26.7) 4 (33.3) 11 (26.2) 2 (12.5) 20 (25.3) 11 (21.2) 18 (26.5) 7 (24.1)
aad-6 6 (20) 1 (8.3) 6 (14.3) 6 (37.5) 13 (16.5) 11 (21.2) 14 (20.6) 7 (24.1)
β-Lactams blaTEM 26 (86.7) 9 (75.0) 36 (85.7) 14 (87.5) 66 (83.5) 48 (92.3) 60 (88.2) 24 (82.8)
blaIMP 16 (53.3) 3 (25.0) 7 (16.7) 7 (43.8) 15 (19.0) 13 (25.0) 14 (20.6) 9 (31.0)
blaSPM-1 0 (0) 0 (0) 0 (0) 1 (6.3) 1 (1.3) 0 (0) 1 (1.5) 0 (0)
Macrolides ermA/TR 0 (0) 0 (0) 2 (4.8) 1 (6.3) 7 (8.9) 6 (11.5) 7 (10.3) 0 (0)
ermB 17 (56.7) 5 (41.7) 28 (66.7) 6 (37.5) 47 (59.5) 27 (51.9) 42 (61.8) 16 (55.2)
mdfA/mefE 0 (0) 0 (0) 1 (2.4) 0 (0) 0 (0) 1 (1.9) 0 (0) 0 (0)
ermC 0 (0) 0 (0) 1 (2.4) 0 (0) 0 (0) 1 (1.9) 0 (0) 0 (0)
Quinolones gyrA 1 (3.3) 1 (8.3) 1 (2.4) 1 (6.3) 1 (1.3) 1 (1.9) 0 (0) 1 (3.4)
Streptomycin rrs 1 (3.3) 1 (8.3) 0 (0) 1 (6.3) 3 (3.8) 3 (5.8) 4 (5.9) 1 (3.4)
Sulfonamides sul1 23 (76.7) 6 (50) 32 (76.2) 9 (56.3) 56 (70.9) 1 (1.9) 55 (80.9) 23 (79.3)
sul2 9 (30.0) 1 (8.3) 12 (28.6) 6 (37.5) 29 (36.7) 37 (71.2) 29 (42.6) 9 (31.0)
Tetracyclines tetD 0 (0) 0 (0) 1 (2.4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
tetK 2 (6.7) 2 (16.7) 2 (4.8) 3 (18.8) 4 (5.1) 3 (5.8) 2 (2.9) 3 (10.3)
tetL 5 (16.7) 2 (16.7) 9 (21.4) 3 (18.8) 16 (20.3) 12 (23.1) 16 (23.5) 6 (20.7)
tetM 21 (70.0) 10 (83.3) 34 (81) 11 (68.8) 61 (77.2) 37 (71.2) 54 (79.4) 22 (75.9)
tetO 13 (43.3) 5 (41.7) 15 (35.7) 3 (18.8) 28 (35.4) 18 (34.6) 26 (38.2) 11 (37.9)
1CX = cephalexin; CRO = ceftriaxone; E = erythromycin; NOR = norfloxacin; K = kanamycin; S = streptomycin; SM = sulfonamide; TE = 
tetracycline.
Table 7. Cox proportional hazard model describing the association between bacterial survival with increasing 
concentrations of different antimicrobial drugs and the presence of the specific antimicrobial resistant genes
Antimicrobial drug  Resistance gene β1 SE HR2 95% CI3 P-value
Cephalexin blaTEM −0.002 0.329 0.998 0.523–1.903 0.99
 blaIMP 0.444 0.234 1.559 0.986–2.464 0.06
Ceftriaxone blaTEM −0.266 0.248 0.766 0.471–1.245 0.28
 blaIMP 0.191 0.203 1.210 0.812–1.803 0.35
Erythromycin ermA/TR −0.236 0.414 0.790 0.351–1.776 0.57
 ermB 0.480 0.213 1.615 1.063–2.454 0.02
Sulfonamide sul1 0.039 0.264 1.040 0.620–1.744 0.88
 sul2 0.238 0.255 1.268 0.769–2.093 0.35
Tetracycline tetM −0.179 0.243 0.836 0.520–1.345 0.46
 tetK 0.570 0.423 1.769 0.772–4.053 0.18
 tetO −0.105 0.156 0.901 0.664–1.222 0.50
1β = regression coefficient.
2HR = hazard ratio.
395% CI = the reference is the isolates without the gene or the ones with the gene.
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peutic doses and to achieve effective concentrations of 
these drugs. Survival analysis was used to describe the 
association between detection of genes encoding resis-
tance compounds and the respective antimicrobials. 
Survival analysis can help us to investigate the varia-
tions in the growth of S. dysgalactiae with the complete 
range of the tested antimicrobials (Sampimon et al., 
2011).
The panel of antimicrobial agents evaluated in this 
study included those antimicrobials that are routinely 
used on Chinese dairy farms to treat bovine mastitis 
and other infectious diseases. The antimicrobial agents 
to which antimicrobial resistance was demonstrated 
most frequently were kanamycin (89.8%) and sulfon-
amide (83.0%), followed by streptomycin (58.0%), 
erythromycin (47.7%), and tetracycline (33.0%). This 
is not that surprising as kanamycin and streptomycin 
are mainly active against gram-negative bacteria and 
S. dysgalactiae belongs to the group of gram-positive 
bacteria. An intrinsic resistance for most of Streptococ-
cus spp. has also been described for sulfonamide and 
aminoglycosides (Swedberg et al., 1998; Porter and 
Kaplan, 2011). In contrast, in a study of bovine S. 
dysgalactiae isolates from New Zealand, the resistance 
to trimethoprim/sulfamethoxazole was only 17% (Mc-
Dougall et al., 2014). The latter discrepancy between 
our results and those obtained by McDougall et al. 
might be hypothetically explained by the fact that the 
tested molecule was a combination of trimethoprim/
sulfamethoxazole, whereas in our study sulfonamide 
was tested as a single compound. In a recent study, 
Lu et al. (2016) also found a high level of antimicro-
bial resistance against erythromycin, clindamycin, and 
tetracycline in 56 S. dysgalactiae subspecies equisimilis 
isolates that were isolated from humans recovering 
from infectious diseases in 2 territorial hospitals in 
Beijing, China (Lu et al., 2016). Similar findings were 
recently observed in Taiwan (Lo et al., 2015) and Aus-
tria (Leitner et al., 2015). Strikingly, in the current 
study some of the clinical isolates from bovine mastitis 
were found to be resistant to cephalexin (34.1%) and 
ceftriaxone (13.6%; i.e., first- and third-generation 
cephalosporins, respectively). This finding is somewhat 
surprising as resistance of S. dysgalactiae against these 
antimicrobial agents has not been reported before in 
human or veterinary medicine. The observed increasing 
level of resistance against the β-lactam antimicrobials 
might at least partly be explained by the increasing 
use of cephalosporins, more specifically of the third-
generation cephalosporin ceftiofur, for the treatment of 
infectious diseases on Chinese dairy farms (Ali et al., 
2016). The increasing use of β-lactam antimicrobials 
might have resulted in a selective pressure toward the 
more resistant isolates.
The phenotypic antimicrobial resistance profiles of 
the recovered S. dysgalactiae isolates not only differed 
between herds but also within herds. The latter ob-
servation strongly indicates that the isolates causing 
clinical mastitis on one single farm may belong to dif-
ferent strain types. On the other hand, in one herd, the 
same phenotypic antimicrobial resistance pattern was 
observed in 7 S. dysgalactiae isolates recovered from 7 
Figure 4. Streptococcus dysgalactiae survival curve in varying concentrations of erythromycin. Survival of bacteria without (dashed line) or 
with (solid line) PCR-based detection of ermB in different concentrations of erythromycin. With the increasing concentration of erythromycin, 
the survival probability of S. dysgalactiae without (dashed line) and with (solid line) PCR-based detection of ermB showed a significant differ-
ence.
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different clinical mastitis cases, suggesting the presence 
of a common infection source. The latter finding could 
be indicative for the contagious spread of S. dysgalac-
tiae between cows during milking via teat liners, hands, 
and so on (Lundberg et al., 2014). Still, because no mo-
lecular strain-typing was performed via sophisticated 
techniques such as pulsed field gel-electrophoresis or 
multi-locus sequencing typing, caution is needed in the 
interpretation of this finding.
In S. dysgalactiae isolates carrying blaTEM or 
blaIMP gene, the prevalence of phenotypic resistance 
against cephalexin was higher than against ceftriaxone. 
Only 12 of 30 isolates that showed resistance against 
cephalexin were also found to be resistant against cef-
triaxone. Ceftriaxone belongs to the third generation 
of cephalosporin, and it was introduced to the market 
more recently and has not been used that long com-
pared with first-generation cephalosporins including 
cephalexin. The latter finding might stress the positive 
relationship between the antimicrobial drug use and the 
spread of antimicrobial resistance within a population.
Interestingly, all S. dysgalactiae isolates carried at 
least one resistance gene, whereas only a small number 
of S. dysgalactiae isolates showed phenotypic resistance 
against the associated antimicrobial. Although a trend 
toward a positive association between the presence of 
the blaTEM gene and bacterial survival was observed, 
comparison of survival curves for isolates with and 
without resistance genes to cephalexin and ceftriaxone 
also showed that several bla-gene positive isolates did 
not survive at low cephalexin or ceftriaxone concentra-
tions (or both). This intriguing finding might be due 
to the lack of gene expression without induction as has 
already been described for Staphylococcus aureus (De 
Oliveira et al., 2000) or lack of functionality (Rahman 
et al., 2005). Conversely, 16 isolates were found to be 
phenotypically resistant to norfloxacin, whereas only 
one single isolate was detected to carry gyrA. The latter 
finding might be explained by mutation in the primer 
binding sites of resistance genes or the existence of not 
yet identified resistance genes (Haveri et al., 2005). 
Clearly, phenotypic resistance is not inevitably indica-
tive for the presence of resistance genes, and vice versa. 
A similar discrepancy was reported by Sampimon et 
al. (2011) in which the phenotypic and genotypic 
antimicrobial resistance of bovine CNS isolates was 
investigated. A larger data set is needed to unequivo-
cally determine the association between the presence of 
antimicrobial resistance genes and the phenotypic re-
sistance patterns. Comprehensive consideration of the 
genotypic resistance and phenotypic resistance profiles 
could make the use of medication in case of clinical 
disease safer, more effective, and less costly.
CONCLUSIONS
The prevalence of S. dysgalactiae isolates recovered 
from milk samples of bovine mastitis cases and their 
antimicrobial resistance profiles considerably differ be-
tween and within dairy herds in China. Survival analysis 
showed a significant association between the presence 
of ermB and survival of the S. dysgalactiae isolates at 
increasing erythromycin concentrations. However, no 
other statistically significant associations were observed 
between the phenotypic and genotypic resistance pro-
files. The considerable variations in the prevalence 
and phenotypic and genotypic antimicrobial resistance 
profiles among Chinese dairy herds strongly suggest the 
need for antimicrobial susceptibility surveillance at the 
herd level to ensure optimal treatment results.
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